Psychiatric medication management for Pompano Beach — residential-level optimization, 28 minutes away.

RECO Immersive is 28 minutes north of Pompano Beach in Delray Beach — close enough to keep family accessible from Cresthaven or Lighthouse Point, far enough to break the daily patterns that let outpatient regimens stall. Psychiatry is embedded in the residential day rather than scheduled around it: observed adherence at every administration, a medication-driven lab cadence with weekly lithium and valproate troughs during titration, and integration with concurrent rTMS or ketamine when interventional treatment is on the plan. Discharge produces a specific, transferable medication plan the outpatient team can actually use.

Pompano Beach sits 18 miles south of RECO Immersive’s Delray Beach campus — a 28-minute drive north on I-95 outside rush hour, longer during the afternoon backup at Atlantic Boulevard. For clients from Cresthaven, Lighthouse Point, Sea Ranch Lakes, or Hillsboro Shores, that distance is short enough to keep family accessible and long enough to break the daily rhythms that let outpatient regimens stall. RECO Immersive is a residential program for adults whose depression, anxiety, PTSD, or bipolar disorder needs continuous psychiatric medication management rather than another weekly appointment.

What observed adherence changes about prescribing

In outpatient care, whether a client actually takes each dose as prescribed is inferred from self-report and pill counts, both of which are unreliable. A patient on sertraline who quietly skips weekend doses will describe the medication as ineffective at the next visit, and the prescriber has no way to separate that from genuine non-response. In residential care, adherence is observed — every dose, every day, documented at administration. That single change removes the largest source of noise from every dose-response decision.

The value shows up quickly on medications with narrow therapeutic windows. Lithium at 900 mg means nothing without a serum level, and that level means nothing without confirmed adherence in the preceding 48 hours. Valproate is the same. Atypical antipsychotics like quetiapine and olanzapine are titrated largely against tolerability, which is compromised at home by variable adherence and by underreported side effects. In residential care, those side effects surface within hours and are addressed at the next contact rather than accumulating until the client silently discontinues.

Daily contact also compresses the timeline for recognizing a failed trial. A two-week outpatient interval means a poorly tolerated aripiprazole titration can consume a full month before the plan changes; residential psychiatry closes that gap to days.

Lab monitoring during a residential stay

Baseline labs are drawn on admission and reviewed before any prescribing decision that requires them. The standard panel includes CBC, comprehensive metabolic panel, TSH, B12 and folate, vitamin D, fasting lipids, HbA1c, urine drug screen, and urine pregnancy where indicated. Cardiovascular history and current medication list determine whether a baseline EKG is added; QTc-prolonging agents like citalopram, quetiapine, and methadone are not continued at meaningful doses without one.

Medication-specific monitoring is then built into the residential cadence rather than negotiated around the client’s schedule. Lithium levels are drawn weekly during titration and then every one to two weeks once a target trough is established, always as a 12-hour trough rather than a random level. Valproate follows the same pattern with liver function and, where clinically warranted, ammonia. Atypical antipsychotics carry weight, glucose, and lipid trends across the stay, and metabolic monitoring is documented at admission and again before discharge so the outpatient team inherits a real baseline. Clozapine, where appropriate, follows REMS-mandated ANC monitoring.

The point of this cadence is that dose optimization requires reliable data, and reliable data requires drawing labs when the pharmacology dictates rather than when the client can reach a lab.

Coordination with concurrent interventional treatment

A meaningful subset of residential clients are candidates for interventional treatment concurrent with residential care — most commonly rTMS at 3,000 pulses per session at 120% of motor threshold across a standard 36-session course, or IV ketamine and intranasal esketamine for treatment-resistant depression. When those tracks run in parallel, the two plans have to be coordinated by a single team rather than negotiated across independent prescribers.

That coordination has real content. Oral antidepressant adherence during a TMS course affects response and needs to be observed rather than assumed. Benzodiazepines and anticonvulsants can attenuate TMS response and are reviewed against the interventional plan before dosing decisions are finalized. Around ketamine or esketamine sessions, the psychiatry team adjusts sedating agents, monitors blood pressure trends, and documents dissociation and PHQ-9 response between visits. Interventional gains — a two- or three-point drop in PHQ-9 that stabilizes across a week — are folded into the ongoing pharmacology plan rather than treated as a separate story.

Because RECO Health runs the interventional program and RECO Immersive runs the residential program under the same clinical leadership, the psychiatrist prescribing the SSRI is aware of Friday’s ketamine session, and the interventional team is aware of last Tuesday’s lithium level.

The medication plan the client leaves with

Discharge is not the end of pharmacologic treatment; it is the handoff. The document that transfers with the client — to the RECO Health outpatient team or to a home-community prescriber — has to be specific enough to be usable. That means the current regimen with doses and timing, the rationale for each medication, the trials and failures that produced the current plan, monitoring schedules for anything requiring labs, and named next-step contingencies for foreseeable outcomes.

The client leaves knowing what medication they are on, why, what to watch for, and what the first outpatient visit will focus on. Clients stepping down to PHP or IOP at RECO Health continue under the same psychiatry team, which removes the reconciliation problem entirely. Clients returning to a home prescriber in Broward County — including established practices in Pompano Beach, Lighthouse Point, and Fort Lauderdale — leave with a discharge summary written to be read by another clinician rather than filed.

The most common cause of relapse in the eight weeks after a residential stay is medication drift — dose changes made without the context that produced the discharge regimen. A specific, defensible, transferable plan is the countermeasure.

What to expect in the first 72 hours

Admission begins with a psychiatric evaluation, a full medical history, and a review of every prior medication trial with dose, duration, response, and reason for discontinuation. Standardized assessments are administered at intake and repeated across the stay — PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for PTSD, YBOCS for OCD, ASRS for adult ADHD, and CIWA or COWS where withdrawal management is part of the presentation. These scales are the measurement infrastructure that lets the psychiatry team distinguish real response from noise.

Within the first 72 hours, the initial medication decisions are usually smaller than clients expect. Existing regimens are stabilized before changes, active side effects are addressed, and medically necessary detox is handled — buprenorphine-based induction for opioids or symptom-triggered benzodiazepine tapers under CIWA monitoring for alcohol. Naltrexone induction, where indicated, follows the detox window. Larger regimen changes — augmentation, switches, cross-tapers — come only once baseline labs return and the team has seen the client across enough contacts to trust the picture.

Insurance and admissions from Pompano Beach

RECO Immersive works with most major commercial insurers, including Florida Blue, BCBS, Aetna, Cigna, UnitedHealthcare, and Humana. Verification of benefits is completed before admission, and residential level of care is authorized against ASAM Criteria dimensions or InterQual/MCG psychiatric criteria based on documented severity, safety concerns, and outpatient treatment history. For Pompano Beach clients, the admissions team can typically confirm coverage and a level-of-care determination within the same business day.

Transport is 18 miles north on I-95 to the Delray Beach campus. Admissions coordinates arrival for clients coming directly from home, from a Broward County emergency department, or as a step-down from acute inpatient care. Once admitted, family communication is coordinated through the treatment team with the client’s written consent under the same HIPAA and 42 CFR Part 2 framework that governs the rest of the record.

Serving residents of: Cresthaven, Lighthouse Point, Sea Ranch Lakes, Hillsboro Shores.